Blaine Davis
CIK 1802188 · Chief Financial Officer · last filed 2026-01-08
Blaine Davis is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing shows the insider sold $72.2K of RNAC on Jan 8, 2026. Across all open-market trades the lifetime net is −$181.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.23M
3
12
-$181.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RNAC | Chief Financial Officer | 121,220 | $9.51 | $1.15M | -$206.3K | 6 | 2026-01-08 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Chief Financial Officer | — | $0.88 | — | $0 | 1 | 2022-11-30 |
| TARA | Chief Financial Officer | 20,662 | $3.90 | $80.6K | $25.0K | 5 | 2022-07-19 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-08 | RNAC | Sell (S) | −10,591 | -$72.2K | EDGAR |
| 2026-01-06 | RNAC | Grant (A) | +37,000 | $0 | EDGAR |
| 2025-01-07 | RNAC | Sell (S) | −7,989 | -$134.0K | EDGAR |
| 2025-01-06 | RNAC | Grant (A) | +22,000 | $0 | EDGAR |
| 2024-01-04 | RNAC | Grant (A) | +2,424,000 | $0 | EDGAR |
| 2023-11-15 | RNAC | Disp (D) | — | $0 | EDGAR |
| 2022-11-30 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-07-19 | TARA | Tax (F) | −5,081 | -$15.9K | EDGAR |
| 2022-01-05 | TARA | Grant (A) | +14,100 | $0 | EDGAR |
| 2021-01-21 | TARA | Grant (A) | — | $0 | EDGAR |